MedTrace Logo

Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities

NCT00501189 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-06-11

No results posted yet for this study

Summary

This project will compare the rate of regression of minimally abnormal Pap smears to normal in women who receive Gardasil to a historical control group.

Research hypothesis: Women with low grade cervical dysplasia on Papanicolaou (Pap) smear that receive Gardasil vaccination will revert to a normal within one year at a rate 33% higher than historical controls that did not receive Gardasil vaccination.

Conditions

  • Papillomavirus Infections

Interventions

BIOLOGICAL

human papillomavirus vaccine L1, type 6,11,16,18

Subjects are those getting gradasil vaccination already. This is really not an intervention

Sponsors & Collaborators

  • Eisenhower Army Medical Center

    lead FED

Principal Investigators

  • Dean A. Seehusen, MD, MPH · Eisenhower Army Medical Center

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2007-09-01
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501189 on ClinicalTrials.gov